by Ryan Paolicelli | Aug 17, 2022
This piece first appeared in European Pharmaceutical Review on 17 August 2022. Here AMR Industry Alliance representatives Melissa Gong Mitchell and Steve Brooks discuss how the Alliance is mobilising the life sciences sector in combatting antimicrobial resistance...
by Ryan Paolicelli | Jul 15, 2022
Report by One Health Trust says acknowledging antimicrobial resistance in regulatory frameworks for accelerated drug approval could improve access to new antibiotics. A report assessing the current climate for antimicrobial innovation in Brazil, India, and South...
by Ryan Paolicelli | Jun 14, 2022
A coalition of drugmakers is introducing new standards aimed at curbing the release of antibiotic waste into the environment amid growing concerns over drug resistance that’s been linked to more than a million annual deaths globally. The guidelines will...
by Ryan Paolicelli | Jun 14, 2022
LONDON, June 14 (Reuters) – In the absence of global standards limiting toxic emissions produced by antibiotics at the point of manufacture, the pharmaceutical industry has come up with its own standard. The AMR Industry Alliance – a coalition of...
by Jane Schumacher | May 5, 2022
Health Europa Quarterly has published its twenty-first issue which features AMR, as well as the AMR Industry Alliance’s Progress Report, acknowledging “the urgent need to facilitate a sustainable market for new antibiotics,” and that “the...
